-
Endpoints News3 weeks ago
Novo wins FDA approval for high-dose Wegovy under commissioner’s voucher
The FDA approved a high-dose version of Novo Nordisk’s blockbuster weight loss injection Wegovy, giving its go-ahead about two months faster than normal thanks to a...
-
Endpoints News3 weeks ago
Verily raises $300M, sheds Alphabet’s majority control
Verily has raised $300 million in new, outside funding that ends parent company Alphabet’s controlling position in the healthcare innovation company, Endpoints News has learned exclusively....
-
Endpoints News3 weeks ago
TerraPower’s $450M radioisotope factory; Lilly’s $126M Japan budget
TerraPower Isotopes, a subsidiary of founder Bill Gates’ nuclear company TerraPower, is building an actinium-225 factory in Philadelphia. Production will start in 2029. TerraPower Isotopes said...
-
Endpoints News3 weeks ago
CSL says its hemophilia B gene therapy is out of stock
CSL Behring disclosed a “temporary global stockout” of its gene therapy for hemophilia B that it says could delay treatment for some patients. In a letter...
Uncategorized34 minutes ago
Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off
Uncategorized40 minutes ago
STAT+: Gilead to buy cancer biotech Tubulis for more than $3 billion
Uncategorized53 minutes ago
